Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
Through advanced training in the EvexiPEL Method, EVEXIAS Health Solutions delivers the clinical expertise and strategic support providers need to improve patient outcomes and build stronger practices
Conclusion: Clinical Translation and Future Perspectives BPC-157 represents a promising investigational peptide with extensive preclinical evidence supporting tissue regeneration, cytoprotection, and healing enhancement across multiple organ systems
5/5 mg vial + 2 mL BAC water: Concentration = 2,500 mcg BPC-157 + 2,500 mcg TB-500 per mL 250 mcg dose (of each) = 10 units (0.1 mL) on a 100-unit insulin syringe 500 mcg dose (of each) = 20 units (0.2 mL) on a 100-unit insulin syringe Doses per vial: 20 doses at 250 mcg each, or 10 doses at 500 mcg each Supplies Needed (4-Week Loading at 500 mcg/day) 3 vials BPC-157/TB-500 blend (5/5 mg each) provides 30 doses at 500 mcg, covers 28 days with margin 3 vials bacteriostatic water (30 mL each) 30 insulin syringes (2931 gauge, 100-unit) Alcohol prep pads Administration Injection Technique Standard subcutaneous injection
May reverse learning deficits in experimental Alzheimers models
US$ 27.80
US$ 25.00
US$ 25.73
US$ 27.12
US$ 29.71
US$ 27.55
US$ 28.84
US$ 22.09
US$ 24.51
US$ 25.72
US$ 28.92
US$ 23.11